SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jesspro who wrote (4448)1/9/2017 10:04:52 PM
From: jaybe5 Recommendations

Recommended By
ghmm
mulanoon2007
rkrw
tktom
xr1

  Read Replies (1) of 4474
 
I think its fair, but of course I hoped for more, or at least addl. CVRs for '788. However, if '788 turns out to be a dud and the immunokinase platform and TKIs were just window dressing, then its actually a good deal. Only time will tell, it will all get lost in the noise at Takeda. I did have a hunch in late Q4 when they delayed moving into already completed HQ, and of course the pona price increases all make sense now.

Its been a rough and wild ride for me since 2004, but all has ended well. Time to scour the pipelines of others for another big adventure.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News